Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327
European Journal of Clinical Pharmacology1991Vol. 40(2), pp. 169–173
Citations Over TimeTop 10% of 1991 papers
C. J. Bench, Gary Price, Adriaan A. Lammertsma, JE Cremer, S. K. Luthra, David R. Turton, Raymond J. Dolan, R. Kettler, Jasper Dingemanse, M. Da Prada, Kathleen Bizière, G. R. McClelland, Virginia Jamieson, Nolan Wood, R. S. J. Frackowiak
Related Papers
- → Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer's disease patients(2002)98 cited
- → The oxidation of tryptamine by the two forms of monoamine oxidase in human tissues(1986)40 cited
- → Deamination of 5‐Hydroxytryptamine by Both Forms of Monoamine Oxidase in the Rat Brain(1982)126 cited
- [An endogenous inhibitor of monoamine oxidase A (tribulin A) from brain: purification and structure identification].(1995)
- → Inhibition of Monoamine Oxidases (MAOs) by Green Tea Extracts(2018)